Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Molecular biomarkers for cancer immunotherapy

Molecular biomarkers for cancer immunotherapy

US Patent 11939637 · Granted Mar 26, 2024

Estimated economic value: $29,931,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for profiling the T-cell-receptor repertoire2025
Immunogenic compositions and use thereof2025
Methods for predicting outcomes and treating colorectal cancer using a cell atla2025
Method for predicting HLA-binding peptides using protein structural features2025
Protein antigens and uses thereof2025
Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes a2025
Multi-stage, multiplexed target isolation and processing from heterogeneous popu2025
HLA-based methods and compositions and uses thereof2024
HLA-based methods and compositions and uses thereof2024
Treatment of aging-associated conditions by DNA degradation2023
HLA-based methods and compositions and uses thereof2023
HLA-based methods and compositions and uses thereof2023